Dipeptidyl Peptidase 4/Midline-1 Axis Promotes T Lymphocyte Motility in Atherosclerosis.
Xiaoquan RaoMichael RazaviGeorgeta MihaiYingying WeiZachary BraunsteinMatthew B FriemanXiao Jian SunQuan GongJun ChenGang ZhaoZheng LiuMichael J QuonLingli DongSanjay RajagopalanJi-Xin ZhongPublished in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
T cells play a crucial role in atherosclerosis, with its infiltration preceding the formation of atheroma. However, how T-cell infiltration is regulated in atherosclerosis remains largely unknown. Here, this work demonstrates that dipeptidyl peptidase-4 (DPP4) is a novel regulator of T-cell motility in atherosclerosis. Single-cell ribonucleic acid (RNA) sequencing and flow cytometry show that CD4 + T cells in atherosclerotic patients display a marked increase of DPP4. Lack of DPP4 in hematopoietic cells or T cells reduces T-cell infiltration and atherosclerotic plaque volume in atherosclerosis mouse models. Mechanistically, DPP4 deficiency reduces T-cell motility by suppressing the expression of microtubule associated protein midline-1 (Mid1) in T cells. Deletion of either DPP4 or Mid1 inhibits chemokine-induced shape change and motility, while restitution of Mid1 in Dpp4 -/- T cell largely restores its migratory ability. Thus, DPP4/Mid1, as a novel regulator of T-cell motility, may be a potential inflammatory target in atherosclerosis.
Keyphrases
- cardiovascular disease
- biofilm formation
- single cell
- flow cytometry
- transcription factor
- poor prognosis
- rna seq
- pseudomonas aeruginosa
- staphylococcus aureus
- escherichia coli
- oxidative stress
- ejection fraction
- bone marrow
- coronary artery disease
- mouse model
- candida albicans
- prognostic factors
- cell cycle arrest
- climate change
- cell death
- endothelial cells
- diabetic rats
- cell proliferation
- patient reported
- human health